与螺旋体相关的分子是通过免疫调节对抗1型糖尿病的新策略
Chun-Lian Tang1, Zhan Lian2, Fan-Rong Ding1
1Wuchang Hospital, Wuhan University of Science and Technology, Wuhan 430063, China.
Parasitology international
|October 17, 2023
概括
顺杆菌感染可能通过调节免疫反应提供新的1型糖尿病治疗方法. 寄生分子影响免疫细胞,促进调节性T细胞和平衡潜在治疗策略的免疫轴.
科学领域:
- 免疫学 免疫学 免疫学
- 寄生虫学的寄生虫学
- 内分泌学 在内分泌学.
背景情况:
- 1型糖尿病涉及1型免疫反应.
- 顺虫感染和1型糖尿病之间存在负相关性.
- schistosoma感染对1型糖尿病的保护机制涉及先天性和适应性免疫.
研究的目的:
- 为了审查类型1糖尿病治疗的免疫调节中杆菌感染的机制.
- 探索与schistosoma相关的分子在调节1型糖尿病相关的免疫反应中的作用.
- 扩展之前关于调节性T细胞在Schistosoma介导的保护中的发现.
主要方法:
- 关于和1型糖尿病的研究的文献综述.
- 对免疫细胞组成和巨细胞极化变化的分析.
- 检查Th1/Th2和Th17/Treg免疫反应轴的变化.
主要成果:
- 与schistosoma相关的分子会影响免疫细胞的组成和巨细胞的两极分化.
- 增加自然杀手T细胞被观察到与schistosoma感染.
- 螺旋体调节自适应性免疫反应,包括Th1/Th2和Th17/Treg平衡.
结论:
- 顺虫感染为1型糖尿病提供了潜在的治疗途径.
- schistosoma衍生分子为治疗1型糖尿病提供了对免疫调节的见解.
- 对这些机制的进一步研究可能会导致新的抗炎治疗方法.
更多相关视频
06:27Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
16.8K
11:31High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
7.9K
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Glucagon-like Receptor Agonists
334
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
334
Psychoneuroimmunology: Diabetes and Cancer
31
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
31
Pathophysiology of Diabetes
956
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
956
Dipeptidyl Peptidase 4 Inhibitors
192
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
192
